Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
Abstract The mutational spectrum and prognostic factors of NRAS-mutated (NRAS mut) acute myeloid leukemia (AML) are largely unknown. We performed next-generation sequencing (NGS) in 1,149 cases of de novo AML and discovered 152 NRAS mut AML (13%). Of the 152 NRAS mut AML, 89% had at least one compan...
Guardado en:
Autores principales: | Shujuan Wang, Zhenzhen Wu, Tao Li, Yafei Li, Weiqiong Wang, Qianqian Hao, Xinsheng Xie, Dingming Wan, Zhongxing Jiang, Chong Wang, Yanfang Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/270fb347cb7e47d096b6fa223960d43d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
por: Feng Wang, et al.
Publicado: (2021) -
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
por: Sibylle Cocciardi, et al.
Publicado: (2019) -
BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Najla Fakhruddin, et al.
Publicado: (2017) -
KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
por: Olga I. Brovkina, et al.
Publicado: (2021) -
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
por: Feng-Ting Dao, et al.
Publicado: (2021)